These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4070336)

  • 21. Reduction in ethanol preference following injection of centrally and peripherally acting antimuscarinic agents.
    Rezvani AH; Overstreet DH; Janowsky DS
    Alcohol Alcohol; 1990; 25(1):3-7. PubMed ID: 2334493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural transplants disrupt the blood-brain barrier and allow peripherally acting drugs to exert a centrally mediated behavioral effect.
    Sandberg PR; Nash DR; Calderon SF; Giordano M; Shipley MT; Norman AB
    Exp Neurol; 1988 Oct; 102(1):149-52. PubMed ID: 3181349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of methscopolamine, physostigmine, and neostigmine on neuron activity in the midbrain, the hippocampus, and the hypothalamus in the behaving rat.
    Olds ME; Eibergen R
    Brain Res; 1973 Feb; 50(2):315-30. PubMed ID: 4705501
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylscopolamine and conditioned location avoidance.
    Hughes RN; Blampied NM; Anderson GJ; Woollett GJ
    Pharmacol Biochem Behav; 1989 Aug; 33(4):913-4. PubMed ID: 2616611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scopolamine treatment and fimbria-fornix lesions: mimetic effects on radial maze performance.
    Cassel JC; Kelche C
    Physiol Behav; 1989 Sep; 46(3):347-53. PubMed ID: 2623054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic activation of rhombencephalic neurones controlling oesophageal peristalsis in the rat.
    Bieger D
    Neuropharmacology; 1984 Dec; 23(12A):1451-64. PubMed ID: 6098853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chin rub CRs may reflect conditioned sickness elicited by a lithium-paired sucrose solution.
    Parker LA; MacLeod KB
    Pharmacol Biochem Behav; 1991 Dec; 40(4):983-6. PubMed ID: 1667827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants.
    Maeda N; Matsuoka N; Yamaguchi I
    Brain Res; 1990 Dec; 537(1-2):163-8. PubMed ID: 1982238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
    Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
    Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of physostigmine on cues produced by electrical stimulation of the ventral tegmental area using two discrimination procedures.
    Druhan JP; Martin-Iverson MT; Wilkie DM; Fibiger HC; Phillips AG
    Pharmacol Biochem Behav; 1987 Oct; 28(2):261-5. PubMed ID: 3685060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cholinergic system, amnesia and memory.
    Lewis DJ; Bregman NJ
    Physiol Behav; 1972 Mar; 8(3):511-4. PubMed ID: 5064483
    [No Abstract]   [Full Text] [Related]  

  • 37. Relearning at different times after training as affected by centrally and peripherally acting cholinergic drugs in the mouse.
    Squire LR; Glick SD; Goldfarb J
    J Comp Physiol Psychol; 1971 Jan; 74(1):41-5. PubMed ID: 5163699
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologically specific pretreatment effects on apomorphine-mediated conditioned taste aversions in rats.
    Pratt JA; Stolerman IP
    Pharmacol Biochem Behav; 1984 Apr; 20(4):507-11. PubMed ID: 6728868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of scopolamine and methylscopolamine on the performance of a fixed-ratio discrimination in squirrel monkeys.
    Pakarinen ED; Moerschbaecher JM
    Pharmacol Biochem Behav; 1993 Apr; 44(4):815-9. PubMed ID: 8469694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinergic regulation of sexual behavior in female hamsters.
    Dohanich GP; McMullan DM; Brazier MM
    Physiol Behav; 1990 Jan; 47(1):127-31. PubMed ID: 2326327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.